for people ages 4 years and up (full criteria)
at Sacramento, California and other locations
study started
completion around
Principal Investigator
by Craig McDonald, MD



This study will follow participants who are screened and confirmed with a genetic diagnosis of Limb-girdle muscular dystrophy type 2E (LGMD2E/R4), Limb-girdle muscular dystrophy type 2D (LGMD2D/R3), or Limb-girdle muscular dystrophy type 2C (LGMD2C/R5). These enrolled participants will be followed to evaluate mobility and pulmonary function for up to 3 years after enrollment. Additional participant data will be collected from the time the individual began experiencing LGMD symptoms to the present.

Official Title

Journey: A Global, Multicenter, Longitudinal Study of the Natural History of Subjects With Limb Girdle Muscular Dystrophy (LGMD) Type 2E (LGMD2E/R4), Type 2D (LGMD2D/R3), and Type 2C (LGMD2C/R5)


Limb-girdle Muscular Dystrophy, North Star Assessment for Dysferlinopathy (NSAD), Performance of Upper Limb (PUL), Pulmonary function tests (PFTs), Ambulatory, Non-Ambulatory, Limb-girdle, LGMD, sarcoglycanopathy, β -sarcoglycan, Muscular Dystrophy, α -sarcoglycan, γ -sarcoglycan, LGMD-2D/R3, LGMD-2E/R4, LGMD-2C/R5, Clinical Outcomes Assessment, Muscular Dystrophies, Limb-Girdle Muscular Dystrophies, Sarcoglycanopathies


You can join if…

Open to people ages 4 years and up

  • Male or female participant ≥ 4 years of age with confirmed genetic diagnosis of LGMD2E/R4, LGMD2D/R3, or LGMD2C/R5.

You CAN'T join if...

  • Demonstrates cognitive delay or impairment that could confound motor development, in the opinion of the Investigator.
  • Has a medical condition, in the opinion of the Investigator, that might compromise participants ability to comply with study requirements.
  • Is participating in other interventional study(ies) at the time of enrollment in this study.


  • University of California, Davis Health Dept of PM&R accepting new patients
    Sacramento California 95817 United States
  • University of California San Diego accepting new patients
    La Jolla California 92037 United States

Lead Scientist at UC Davis

  • Craig McDonald, MD
    Professor, Physical Medicine and Rehabilitation, School of Medicine. Authored (or co-authored) 237 research publications


accepting new patients
Start Date
Completion Date
Sarepta Therapeutics, Inc.
Click here to access the website,, for additional information for the study. Sign up for this study
Study Type
Expecting 90 study participants
Last Updated